Successful treatment of refractory epidermolysis bullosa acquisita with intravenous immunoglobulin and dapsone.

McLawhorn, Justin M; Johnson, Andrew W; Kim, Kevin H; Addis, Kristen

McLawhorn, Justin M; Johnson, Andrew W; Kim, Kevin H; Addis, Kristen.

Affiliation

McLawhorn JM; University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Johnson AW; Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, USA.
Kim KH; Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, USA.
Addis K; Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, USA.

Cutis ; 104(2): E20-E21, 2019 Aug.

Article in En | MEDLINE | ID: mdl-31603972

Subject(s)

Dapsone/administration & dosage; Epidermolysis Bullosa Acquisita/drug therapy; Immunoglobulins, Intravenous/administration & dosage; Aged; Drug Therapy, Combination; Epidermolysis Bullosa Acquisita/pathology; Humans; Immunologic Factors/administration & dosage; Male; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Epidermolysis Bullosa Acquisita / Immunoglobulins, Intravenous / Dapsone Limits: Aged / Humans / Male Language: En Journal: Cutis Year: 2019 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links